These processes primarily involve 1) the upregulation of immune checkpoints (such as PD-L1 and CTLA-4), 2) the accumulation of TAMs and regulatory Tregs, and 3) the reprogramming of tumour metabolic pathways. The gene discussed is CD274; the disease is neoplasm.